HEADER TRANSPORT 16-MAR-98 1A7L TITLE DOMINANT B-CELL EPITOPE FROM THE PRES2 REGION OF HEPATITIS B VIRUS IN TITLE 2 THE FORM OF AN INSERTED PEPTIDE SEGMENT IN MALTODEXTRIN-BINDING TITLE 3 PROTEIN CAVEAT 1A7L GLC D 1 HAS WRONG CHIRALITY AT ATOM C1 GLC E 1 HAS WRONG CAVEAT 2 1A7L CHIRALITY AT ATOM C1 GLC F 1 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MALE-B363; COMPND 3 CHAIN: A, B, C; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 3 ORGANISM_TAXID: 32630; SOURCE 4 STRAIN: ED9; SOURCE 5 GENE: MBP MUTANT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PPD91-(DERIVATIVE); SOURCE 10 EXPRESSION_SYSTEM_GENE: MBP MUTANT KEYWDS TRANSPORT, PRES2, EPITOPE, HEPATITIS B, MALTOSE-BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR F.A.SAUL,B.VULLIEZ-LENORMAND,F.LEMA,G.A.BENTLEY REVDAT 7 02-AUG-23 1A7L 1 HETSYN REVDAT 6 29-JUL-20 1A7L 1 CAVEAT COMPND REMARK HET REVDAT 6 2 1 HETNAM FORMUL LINK SITE REVDAT 6 3 1 ATOM REVDAT 5 24-FEB-09 1A7L 1 VERSN REVDAT 4 01-APR-03 1A7L 1 JRNL REVDAT 3 02-NOV-99 1A7L 1 JRNL REVDAT 2 19-OCT-99 1A7L 1 JRNL REVDAT 1 17-JUN-98 1A7L 0 JRNL AUTH F.A.SAUL,B.VULLIEZ-LE NORMAND,F.LEMA,G.A.BENTLEY JRNL TITL CRYSTAL STRUCTURE OF A DOMINANT B-CELL EPITOPE FROM THE JRNL TITL 2 PRES2 REGION OF HEPATITIS B VIRUS IN THE FORM OF AN INSERTED JRNL TITL 3 PEPTIDE SEGMENT IN MALTODEXTRIN-BINDING PROTEIN. JRNL REF J.MOL.BIOL. V. 280 185 1998 JRNL REFN ISSN 0022-2836 JRNL PMID 9654443 JRNL DOI 10.1006/JMBI.1998.1866 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.VULLIEZ-LE NORMAND,F.A.SAUL,P.MARTINEAU,F.LEMA,M.HOFNUNG, REMARK 1 AUTH 2 G.A.BENTLEY REMARK 1 TITL MALTODEXTRIN-BINDING PROTEIN HYBRIDS CARRYING EPITOPES FROM REMARK 1 TITL 2 THE PRES2 REGION OF HEPATITIS B VIRUS: EXPRESSION, REMARK 1 TITL 3 ANTIBODY-BINDING AND PRELIMINARY CRYSTALLOGRAPHIC STUDIES REMARK 1 REF PROTEIN ENG. V. 10 175 1997 REMARK 1 REFN ISSN 0269-2139 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.8 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.1000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 23877 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.286 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.500 REMARK 3 FREE R VALUE TEST SET COUNT : 592 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.03 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2658 REMARK 3 BIN R VALUE (WORKING SET) : 0.2480 REMARK 3 BIN FREE R VALUE : 0.3570 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.96 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 89 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8634 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 48 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.183 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.150 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : RESTRAINTS REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : PARAM.MAL REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOPOL.MAL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1A7L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170492. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NOV-94 REMARK 200 TEMPERATURE (KELVIN) : 290 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : COLLIMATOR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : MARSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24492 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.11900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.41900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.8 REMARK 200 STARTING MODEL: MBP RESIDUES 4 - 362 (PDB ENTRY 1ANF) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN CONCENTRATION 3.0MG/ML, BUFFER REMARK 280 0.1M TRIS-HCL PH 8.5 WITH 0.2 M MGCL2, 1 MM MALTOSE, 26% PEG REMARK 280 4000. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.65000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT CONTAINS THREE REMARK 300 INDEPENDENT MOLECULES OF MALE-B363. EACH IS ASSOCIATED REMARK 300 WITH A BOUND MOLECULE OF MALTOSE SUBSTRATE. REMARK 300 THE FOLLOWING CHAIN IDENTIFIERS ARE USED: CHAIN REMARK 300 A, MALE-B363 MOLECULE 1; CHAIN B, MALE-B363 MOLECULE 2; REMARK 300 CHAIN C, MALE-B363 MOLECULE 3; CHAIN D, HET GROUP REMARK 300 ASSOCIATED WITH MOLECULE 1; CHAIN E, HET GROUP ASSOCIATED REMARK 300 WITH MOLECULE 2; CHAIN F, HET GROUP ASSOCIATED WITH REMARK 300 MOLECULE 3; CHAIN X, SOLVENTS ASSOCIATED WITH MOLECULE 1; REMARK 300 CHAIN Y, SOLVENTS ASSOCIATED WITH MOLECULE 2; CHAIN Z, REMARK 300 SOLVENTS ASSOCIATED WITH MOLECULE 3. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, E REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 64.60000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -35.65000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 MALE-B363 IS AN INSERTION/DELETION MUTANT OF THE E. COLI REMARK 400 MALTODEXTRIN-BINDING PROTEIN (MBP) CARRYING THE AMINO-ACID REMARK 400 SEQUENCE OF A B-CELL EPITOPE FROM THE PRES2 REGION OF THE REMARK 400 HEPATITIS B VIRUS SURFACE ANTIGEN. AMINO ACIDS BELONGING REMARK 400 TO THE PRES2 EPITOPE ARE DESIGNATED 132E TO 145E REMARK 400 (POSITIONS 132-145 OF THE VIRAL SURFACE ANTIGEN). RESIDUES REMARK 400 DESIGNATED 364I, 365I, AND 380I-389I, WHICH FLANK THE REMARK 400 EPITOPE SEGMENT, RESULT FROM THE GENETIC CONSTRUCTION USED REMARK 400 TO PERMIT THE INSERTION. NUMBERING OF THE INSERTED REMARK 400 SEQUENCE IS THUS 364I, 365I, 132E TO 145E, AND 380I TO REMARK 400 389I. THESE RESIDUES REPLACE WILD-TYPE MBP RESIDUES FROM REMARK 400 POSITIONS 364 - 370. THE NUMBERING OF MBP RESIDUES IN THIS REMARK 400 ENTRY CORRESPONDS TO THE SEQUENCE POSITIONS OF WILD-TYPE REMARK 400 MBP. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 1 REMARK 465 ILE A 2 REMARK 465 GLU A 3 REMARK 465 GLU A 384 REMARK 465 MET A 385 REMARK 465 PRO A 386 REMARK 465 ASP A 387 REMARK 465 ALA A 388 REMARK 465 ALA A 389 REMARK 465 LYS B 1 REMARK 465 ILE B 2 REMARK 465 GLU B 3 REMARK 465 PRO B 142E REMARK 465 ALA B 143E REMARK 465 GLY B 144E REMARK 465 GLY B 145E REMARK 465 SER B 146E REMARK 465 GLU B 147E REMARK 465 CYS B 148E REMARK 465 CYS B 149E REMARK 465 GLU B 150E REMARK 465 MET B 151E REMARK 465 PRO B 152E REMARK 465 ASP B 153E REMARK 465 ALA B 154E REMARK 465 ALA B 155E REMARK 465 LYS C 1 REMARK 465 ILE C 2 REMARK 465 GLU C 3 REMARK 465 GLN C 132E REMARK 465 ASP C 133E REMARK 465 PRO C 134E REMARK 465 ARG C 135E REMARK 465 VAL C 136E REMARK 465 ARG C 137E REMARK 465 GLY C 138E REMARK 465 LEU C 139E REMARK 465 TYR C 140E REMARK 465 PHE C 141E REMARK 465 PRO C 142E REMARK 465 ALA C 143E REMARK 465 GLY C 144E REMARK 465 GLY C 145E REMARK 465 SER C 146E REMARK 465 GLU C 147E REMARK 465 CYS C 148E REMARK 465 CYS C 149E REMARK 465 GLU C 150E REMARK 465 MET C 151E REMARK 465 PRO C 152E REMARK 465 ASP C 153E REMARK 465 ALA C 154E REMARK 465 ALA C 155E REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 381I CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLY A 5 N GLY A 5 CA -0.126 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 62 153.86 177.88 REMARK 500 ILE A 108 -56.72 -121.04 REMARK 500 LYS A 144 -169.54 -127.84 REMARK 500 ALA A 168 -77.30 -75.05 REMARK 500 GLU A 381I -157.33 -176.06 REMARK 500 CYS A 382I 134.72 -178.61 REMARK 500 HIS B 39 75.41 -150.54 REMARK 500 TRP B 62 158.09 176.58 REMARK 500 ILE B 108 -55.19 -120.39 REMARK 500 ASN B 150 99.02 -61.41 REMARK 500 ALA B 168 -71.35 -72.98 REMARK 500 TYR B 283 -50.08 -120.47 REMARK 500 TRP C 62 158.27 177.30 REMARK 500 ILE C 108 -57.75 -122.67 REMARK 500 GLU C 172 -122.11 -73.57 REMARK 500 ASN C 173 73.47 -65.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 GLC F 2 DBREF 1A7L A 1 363 UNP P02928 MALE_ECOLI 27 389 DBREF 1A7L B 1 363 UNP P02928 MALE_ECOLI 27 389 DBREF 1A7L C 1 363 UNP P02928 MALE_ECOLI 27 389 SEQRES 1 A 389 LYS ILE GLU GLU GLY LYS LEU VAL ILE TRP ILE ASN GLY SEQRES 2 A 389 ASP LYS GLY TYR ASN GLY LEU ALA GLU VAL GLY LYS LYS SEQRES 3 A 389 PHE GLU LYS ASP THR GLY ILE LYS VAL THR VAL GLU HIS SEQRES 4 A 389 PRO ASP LYS LEU GLU GLU LYS PHE PRO GLN VAL ALA ALA SEQRES 5 A 389 THR GLY ASP GLY PRO ASP ILE ILE PHE TRP ALA HIS ASP SEQRES 6 A 389 ARG PHE GLY GLY TYR ALA GLN SER GLY LEU LEU ALA GLU SEQRES 7 A 389 ILE THR PRO ASP LYS ALA PHE GLN ASP LYS LEU TYR PRO SEQRES 8 A 389 PHE THR TRP ASP ALA VAL ARG TYR ASN GLY LYS LEU ILE SEQRES 9 A 389 ALA TYR PRO ILE ALA VAL GLU ALA LEU SER LEU ILE TYR SEQRES 10 A 389 ASN LYS ASP LEU LEU PRO ASN PRO PRO LYS THR TRP GLU SEQRES 11 A 389 GLU ILE PRO ALA LEU ASP LYS GLU LEU LYS ALA LYS GLY SEQRES 12 A 389 LYS SER ALA LEU MET PHE ASN LEU GLN GLU PRO TYR PHE SEQRES 13 A 389 THR TRP PRO LEU ILE ALA ALA ASP GLY GLY TYR ALA PHE SEQRES 14 A 389 LYS TYR GLU ASN GLY LYS TYR ASP ILE LYS ASP VAL GLY SEQRES 15 A 389 VAL ASP ASN ALA GLY ALA LYS ALA GLY LEU THR PHE LEU SEQRES 16 A 389 VAL ASP LEU ILE LYS ASN LYS HIS MET ASN ALA ASP THR SEQRES 17 A 389 ASP TYR SER ILE ALA GLU ALA ALA PHE ASN LYS GLY GLU SEQRES 18 A 389 THR ALA MET THR ILE ASN GLY PRO TRP ALA TRP SER ASN SEQRES 19 A 389 ILE ASP THR SER LYS VAL ASN TYR GLY VAL THR VAL LEU SEQRES 20 A 389 PRO THR PHE LYS GLY GLN PRO SER LYS PRO PHE VAL GLY SEQRES 21 A 389 VAL LEU SER ALA GLY ILE ASN ALA ALA SER PRO ASN LYS SEQRES 22 A 389 GLU LEU ALA LYS GLU PHE LEU GLU ASN TYR LEU LEU THR SEQRES 23 A 389 ASP GLU GLY LEU GLU ALA VAL ASN LYS ASP LYS PRO LEU SEQRES 24 A 389 GLY ALA VAL ALA LEU LYS SER TYR GLU GLU GLU LEU ALA SEQRES 25 A 389 LYS ASP PRO ARG ILE ALA ALA THR MET GLU ASN ALA GLN SEQRES 26 A 389 LYS GLY GLU ILE MET PRO ASN ILE PRO GLN MET SER ALA SEQRES 27 A 389 PHE TRP TYR ALA VAL ARG THR ALA VAL ILE ASN ALA ALA SEQRES 28 A 389 SER GLY ARG GLN THR VAL ASP GLU ALA LEU LYS ASP GLY SEQRES 29 A 389 SER GLN ASP PRO ARG VAL ARG GLY LEU TYR PHE PRO ALA SEQRES 30 A 389 GLY GLY SER GLU CYS CYS GLU MET PRO ASP ALA ALA SEQRES 1 B 389 LYS ILE GLU GLU GLY LYS LEU VAL ILE TRP ILE ASN GLY SEQRES 2 B 389 ASP LYS GLY TYR ASN GLY LEU ALA GLU VAL GLY LYS LYS SEQRES 3 B 389 PHE GLU LYS ASP THR GLY ILE LYS VAL THR VAL GLU HIS SEQRES 4 B 389 PRO ASP LYS LEU GLU GLU LYS PHE PRO GLN VAL ALA ALA SEQRES 5 B 389 THR GLY ASP GLY PRO ASP ILE ILE PHE TRP ALA HIS ASP SEQRES 6 B 389 ARG PHE GLY GLY TYR ALA GLN SER GLY LEU LEU ALA GLU SEQRES 7 B 389 ILE THR PRO ASP LYS ALA PHE GLN ASP LYS LEU TYR PRO SEQRES 8 B 389 PHE THR TRP ASP ALA VAL ARG TYR ASN GLY LYS LEU ILE SEQRES 9 B 389 ALA TYR PRO ILE ALA VAL GLU ALA LEU SER LEU ILE TYR SEQRES 10 B 389 ASN LYS ASP LEU LEU PRO ASN PRO PRO LYS THR TRP GLU SEQRES 11 B 389 GLU ILE PRO ALA LEU ASP LYS GLU LEU LYS ALA LYS GLY SEQRES 12 B 389 LYS SER ALA LEU MET PHE ASN LEU GLN GLU PRO TYR PHE SEQRES 13 B 389 THR TRP PRO LEU ILE ALA ALA ASP GLY GLY TYR ALA PHE SEQRES 14 B 389 LYS TYR GLU ASN GLY LYS TYR ASP ILE LYS ASP VAL GLY SEQRES 15 B 389 VAL ASP ASN ALA GLY ALA LYS ALA GLY LEU THR PHE LEU SEQRES 16 B 389 VAL ASP LEU ILE LYS ASN LYS HIS MET ASN ALA ASP THR SEQRES 17 B 389 ASP TYR SER ILE ALA GLU ALA ALA PHE ASN LYS GLY GLU SEQRES 18 B 389 THR ALA MET THR ILE ASN GLY PRO TRP ALA TRP SER ASN SEQRES 19 B 389 ILE ASP THR SER LYS VAL ASN TYR GLY VAL THR VAL LEU SEQRES 20 B 389 PRO THR PHE LYS GLY GLN PRO SER LYS PRO PHE VAL GLY SEQRES 21 B 389 VAL LEU SER ALA GLY ILE ASN ALA ALA SER PRO ASN LYS SEQRES 22 B 389 GLU LEU ALA LYS GLU PHE LEU GLU ASN TYR LEU LEU THR SEQRES 23 B 389 ASP GLU GLY LEU GLU ALA VAL ASN LYS ASP LYS PRO LEU SEQRES 24 B 389 GLY ALA VAL ALA LEU LYS SER TYR GLU GLU GLU LEU ALA SEQRES 25 B 389 LYS ASP PRO ARG ILE ALA ALA THR MET GLU ASN ALA GLN SEQRES 26 B 389 LYS GLY GLU ILE MET PRO ASN ILE PRO GLN MET SER ALA SEQRES 27 B 389 PHE TRP TYR ALA VAL ARG THR ALA VAL ILE ASN ALA ALA SEQRES 28 B 389 SER GLY ARG GLN THR VAL ASP GLU ALA LEU LYS ASP GLY SEQRES 29 B 389 SER GLN ASP PRO ARG VAL ARG GLY LEU TYR PHE PRO ALA SEQRES 30 B 389 GLY GLY SER GLU CYS CYS GLU MET PRO ASP ALA ALA SEQRES 1 C 389 LYS ILE GLU GLU GLY LYS LEU VAL ILE TRP ILE ASN GLY SEQRES 2 C 389 ASP LYS GLY TYR ASN GLY LEU ALA GLU VAL GLY LYS LYS SEQRES 3 C 389 PHE GLU LYS ASP THR GLY ILE LYS VAL THR VAL GLU HIS SEQRES 4 C 389 PRO ASP LYS LEU GLU GLU LYS PHE PRO GLN VAL ALA ALA SEQRES 5 C 389 THR GLY ASP GLY PRO ASP ILE ILE PHE TRP ALA HIS ASP SEQRES 6 C 389 ARG PHE GLY GLY TYR ALA GLN SER GLY LEU LEU ALA GLU SEQRES 7 C 389 ILE THR PRO ASP LYS ALA PHE GLN ASP LYS LEU TYR PRO SEQRES 8 C 389 PHE THR TRP ASP ALA VAL ARG TYR ASN GLY LYS LEU ILE SEQRES 9 C 389 ALA TYR PRO ILE ALA VAL GLU ALA LEU SER LEU ILE TYR SEQRES 10 C 389 ASN LYS ASP LEU LEU PRO ASN PRO PRO LYS THR TRP GLU SEQRES 11 C 389 GLU ILE PRO ALA LEU ASP LYS GLU LEU LYS ALA LYS GLY SEQRES 12 C 389 LYS SER ALA LEU MET PHE ASN LEU GLN GLU PRO TYR PHE SEQRES 13 C 389 THR TRP PRO LEU ILE ALA ALA ASP GLY GLY TYR ALA PHE SEQRES 14 C 389 LYS TYR GLU ASN GLY LYS TYR ASP ILE LYS ASP VAL GLY SEQRES 15 C 389 VAL ASP ASN ALA GLY ALA LYS ALA GLY LEU THR PHE LEU SEQRES 16 C 389 VAL ASP LEU ILE LYS ASN LYS HIS MET ASN ALA ASP THR SEQRES 17 C 389 ASP TYR SER ILE ALA GLU ALA ALA PHE ASN LYS GLY GLU SEQRES 18 C 389 THR ALA MET THR ILE ASN GLY PRO TRP ALA TRP SER ASN SEQRES 19 C 389 ILE ASP THR SER LYS VAL ASN TYR GLY VAL THR VAL LEU SEQRES 20 C 389 PRO THR PHE LYS GLY GLN PRO SER LYS PRO PHE VAL GLY SEQRES 21 C 389 VAL LEU SER ALA GLY ILE ASN ALA ALA SER PRO ASN LYS SEQRES 22 C 389 GLU LEU ALA LYS GLU PHE LEU GLU ASN TYR LEU LEU THR SEQRES 23 C 389 ASP GLU GLY LEU GLU ALA VAL ASN LYS ASP LYS PRO LEU SEQRES 24 C 389 GLY ALA VAL ALA LEU LYS SER TYR GLU GLU GLU LEU ALA SEQRES 25 C 389 LYS ASP PRO ARG ILE ALA ALA THR MET GLU ASN ALA GLN SEQRES 26 C 389 LYS GLY GLU ILE MET PRO ASN ILE PRO GLN MET SER ALA SEQRES 27 C 389 PHE TRP TYR ALA VAL ARG THR ALA VAL ILE ASN ALA ALA SEQRES 28 C 389 SER GLY ARG GLN THR VAL ASP GLU ALA LEU LYS ASP GLY SEQRES 29 C 389 SER GLN ASP PRO ARG VAL ARG GLY LEU TYR PHE PRO ALA SEQRES 30 C 389 GLY GLY SER GLU CYS CYS GLU MET PRO ASP ALA ALA HET GLC D 1 12 HET GLC D 2 11 HET GLC E 1 12 HET GLC E 2 11 HET GLC F 1 12 HET GLC F 2 10 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 4 GLC 6(C6 H12 O6) FORMUL 7 HOH *48(H2 O) HELIX 1 1 TYR A 17 THR A 31 1 15 HELIX 2 2 LEU A 43 THR A 53 1 11 HELIX 3 3 HIS A 64 GLN A 72 5 9 HELIX 4 4 LYS A 83 LYS A 88 1 6 HELIX 5 5 PRO A 91 VAL A 97 1 7 HELIX 6 6 ILE A 132 LYS A 142 1 11 HELIX 7 7 PRO A 154 ALA A 163 1 10 HELIX 8 8 ALA A 186 LYS A 200 1 15 HELIX 9 9 TYR A 210 ASN A 218 1 9 HELIX 10 10 PRO A 229 SER A 238 5 10 HELIX 11 11 LYS A 273 ASN A 282 1 10 HELIX 12 12 ASP A 287 ASP A 296 1 10 HELIX 13 13 LYS A 305 LYS A 313 1 9 HELIX 14 14 PRO A 315 LYS A 326 1 12 HELIX 15 15 PRO A 334 ALA A 351 5 18 HELIX 16 16 VAL A 357 SER A 365I 1 9 HELIX 17 17 PRO A 134E ARG A 137E 1 4 HELIX 18 18 TYR B 17 THR B 31 1 15 HELIX 19 19 LEU B 43 VAL B 50 1 8 HELIX 20 20 HIS B 64 SER B 73 5 10 HELIX 21 21 LYS B 83 LYS B 88 1 6 HELIX 22 22 PRO B 91 VAL B 97 1 7 HELIX 23 23 ILE B 132 LYS B 142 1 11 HELIX 24 24 PRO B 154 ALA B 163 1 10 HELIX 25 25 ALA B 186 LYS B 200 1 15 HELIX 26 26 TYR B 210 LYS B 219 1 10 HELIX 27 27 PRO B 229 SER B 238 5 10 HELIX 28 28 LYS B 273 ASN B 282 1 10 HELIX 29 29 ASP B 287 ASP B 296 1 10 HELIX 30 30 LYS B 305 LYS B 313 1 9 HELIX 31 31 PRO B 315 LYS B 326 1 12 HELIX 32 32 PRO B 334 ALA B 351 5 18 HELIX 33 33 VAL B 357 GLN B 132E 1 10 HELIX 34 34 TYR C 17 THR C 31 1 15 HELIX 35 35 LEU C 43 THR C 53 1 11 HELIX 36 36 HIS C 64 GLN C 72 5 9 HELIX 37 37 LYS C 83 LYS C 88 1 6 HELIX 38 38 PRO C 91 VAL C 97 1 7 HELIX 39 39 ILE C 132 LYS C 142 1 11 HELIX 40 40 PRO C 154 ALA C 163 1 10 HELIX 41 41 ALA C 186 LYS C 200 1 15 HELIX 42 42 TYR C 210 ASN C 218 1 9 HELIX 43 43 PRO C 229 SER C 238 5 10 HELIX 44 44 LYS C 273 ASN C 282 1 10 HELIX 45 45 ASP C 287 ASP C 296 1 10 HELIX 46 46 LYS C 305 LYS C 313 1 9 HELIX 47 47 PRO C 315 LYS C 326 1 12 HELIX 48 48 PRO C 334 SER C 352 5 19 HELIX 49 49 VAL C 357 ASP C 363 1 7 SHEET 1 A 2 LEU A 7 TRP A 10 0 SHEET 2 A 2 VAL A 35 GLU A 38 1 N THR A 36 O LEU A 7 SHEET 1 B 3 ILE A 59 ALA A 63 0 SHEET 2 B 3 GLY A 260 ILE A 266 -1 N GLY A 265 O ILE A 60 SHEET 3 B 3 TYR A 106 GLU A 111 -1 N GLU A 111 O GLY A 260 SHEET 1 C 3 MET A 224 ASN A 227 0 SHEET 2 C 3 SER A 114 ASN A 118 -1 N ILE A 116 O THR A 225 SHEET 3 C 3 TYR A 242 THR A 245 -1 N THR A 245 O LEU A 115 SHEET 1 D 2 LYS B 6 TRP B 10 0 SHEET 2 D 2 LYS B 34 GLU B 38 1 N LYS B 34 O LEU B 7 SHEET 1 E 3 ILE B 59 ALA B 63 0 SHEET 2 E 3 GLY B 260 ILE B 266 -1 N GLY B 265 O ILE B 60 SHEET 3 E 3 TYR B 106 GLU B 111 -1 N GLU B 111 O GLY B 260 SHEET 1 F 3 MET B 224 ASN B 227 0 SHEET 2 F 3 SER B 114 ASN B 118 -1 N ILE B 116 O THR B 225 SHEET 3 F 3 TYR B 242 THR B 245 -1 N THR B 245 O LEU B 115 SHEET 1 G 2 LEU C 7 TRP C 10 0 SHEET 2 G 2 VAL C 35 GLU C 38 1 N THR C 36 O LEU C 7 SHEET 1 H 3 ILE C 59 ALA C 63 0 SHEET 2 H 3 GLY C 260 ILE C 266 -1 N GLY C 265 O ILE C 60 SHEET 3 H 3 TYR C 106 GLU C 111 -1 N GLU C 111 O GLY C 260 SHEET 1 I 3 MET C 224 ASN C 227 0 SHEET 2 I 3 SER C 114 ASN C 118 -1 N ILE C 116 O THR C 225 SHEET 3 I 3 TYR C 242 THR C 245 -1 N THR C 245 O LEU C 115 LINK O4 GLC D 1 C1 GLC D 2 1555 1555 1.41 LINK O4 GLC E 1 C1 GLC E 2 1555 1555 1.43 LINK O4 GLC F 1 C1 GLC F 2 1555 1555 1.44 CRYST1 64.600 71.300 123.200 90.00 94.90 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015480 0.000000 0.001327 0.00000 SCALE2 0.000000 0.014025 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008147 0.00000 MTRIX1 1 0.730690 0.634786 -0.251274 -28.92220 1 MTRIX2 1 -0.631036 0.768440 0.106271 -8.44770 1 MTRIX3 1 0.260548 0.080911 0.962064 -8.54460 1 MTRIX1 2 0.887602 0.188515 -0.420268 25.05100 1 MTRIX2 2 0.172008 0.710748 0.682092 -66.33840 1 MTRIX3 2 0.427290 -0.677716 0.598435 4.48720 1